Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House biomaterials liability bill inclusion in HR 10 to be proposed by Rep. Gekas.

This article was originally published in The Gray Sheet

Executive Summary

HOUSE BIOMATERIALS BILL INCLUSION IN PRODUCT LIABILITY LEGISLATION likely will be proposed by Rep. George Gekas (R-Penn.) either during committee mark-up of HR 10 or when the product liability measure reaches the House floor, according to congressional staffers. The biomaterials liability measure is thought to stand a better chance of enactment if it is included in HR 10 rather than left as a stand-alone bill, staffers say. Mark-up of HR 10 by the House Commerce Committee's Commerce, Trade and Hazardous Materials Subcommittee, chaired by Rep. Michael Oxley (R-Ohio), is scheduled to take place Feb. 21.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT003467

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel